Judge Confirms FDA Regulation of Stem Cell Industry
A federal judge confirmed that the FDA has the right to regulate for-profit stem-cell therapy treatments. Autologous treatments may require FDA approval as drugs.
Why Health Companies Need to Know How the FDA and FTC Enforce Regenerative Medicine Industry Violations
Avoid or mitigate potential FDA and FTC enforcement actions against stem cell and regenerative healthcare companies, including for false claims, by learning these legal keys
Why the FDA Won’t Approve Your Regenerative Medicine Practice
Regenerative medicine includes many treatments and products such as stem cell therapy, PRP, and gene therapy. An experienced stem cell and regenerative medicine lawyer can explain the FDA requirements.
